PEG10 Antibody

Code CSB-PA768203LA01HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human adrenal gland tissue using CSB-PA768203LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA768203LA01HU at dilution of 1:100

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) PEG10 Polyclonal antibody
Uniprot No.
Target Names
PEG10
Alternative Names
AA407948 antibody; Edr antibody; Embryonal carcinoma differentiation regulated antibody; Embryonal carcinoma differentiation-regulated protein antibody; HB 1 antibody; HB1 antibody; KIAA1051 antibody; Mammalian retrotransposon-derived protein 2 antibody; Mar2 antibody; Mart2 antibody; MEF3 like 1 antibody; MEF3-like protein 1 antibody; MEF3L antibody; MEF3L1 antibody; MyEF 3 antibody; Myelin expression factor 3-like protein 1 antibody; Paternally expressed 10 antibody; Paternally expressed gene 10 ORF1 antibody; Paternally expressed gene 10 protein antibody; Peg10 antibody; PEG10 protein antibody; PEG10_HUMAN antibody; Putative uncharacterized protein PEG10 antibody; Retrotransposon gag domain containing 3 antibody; Retrotransposon gag domain-containing protein 3 antibody; Retrotransposon-derived gag-like polyprotein antibody; Retrotransposon-derived protein PEG10 antibody; RGAG3 antibody; Ty3/Gypsy-like protein antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Retrotransposon-derived protein PEG10 protein (1-325AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The PEG10 Antibody (Product code: CSB-PA768203LA01HU) is Non-conjugated. For PEG10 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA768203LB01HU PEG10 Antibody, HRP conjugated ELISA
FITC CSB-PA768203LC01HU PEG10 Antibody, FITC conjugated
Biotin CSB-PA768203LD01HU PEG10 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Prevents apoptosis in hepatocellular carcinoma (HCC) cells through interaction with SIAH1, a mediator of apoptosis. May also have a role in cell growth promotion and hepatoma formation. Inhibits the TGF-beta signaling by interacting with the TGF-beta receptor ACVRL1. When overexpressed, induces the formation of cellular extension, such as filipodia in association with ACVRL1. Involved at the immediate early stage of adipocyte differentiation. May bind to the 5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basic protein (MBP) promoter.
Gene References into Functions
  1. PEG10 expression is associated with advanced clinicopathological characteristics and can be used as a prognostic biomarker in patients with solid tumors. PMID: 29727698
  2. Results demonstrated that an increased expression of PEG10 is associated vessel invasion, and the overall survival time of PC patients. E2F-1 mediated PEG10 overexpression promotes pancreatic cancer (PC) cell proliferation via accelerating cell cycle progression and increase migration and invasion through ERK/MMP7 pathway. These results suggest that PEG10 may serve as an oncogene in PC pathogenesis. PMID: 28193232
  3. miR-122 suppresses PEG10 expression via direct binding to the 3'-UTR of the PEG10 transcript. PMID: 27370270
  4. PEG10 expression associates with the lymph node metastasis and overall survival of hepatocellular carcinoma patients.PEG10 expression level is essential for TGF-beta1 induced epithelialmesenchymal transition. PMID: 28004118
  5. Knockdown of PEG10 expression by siRNA could lead to growth arrest and cell apoptosis in diffuse large B cell lymphoma cells in vitro. PMID: 25864113
  6. PEG10 protein could be a potential biomarker predicting early recurrence and recurrence-free survival in HCC patients after curative resection, even in those with normal serum alpha-fetoprotein levels. PMID: 25687862
  7. Study shows that expression level of PEG10 was significantly elevated in breast cancer tissues and associated with distant metastasis and poor clinical outcome and provides evidence that PEG10 is a crucial oncogene. PMID: 26934961
  8. important role in trophoblast proliferation and promotes trophoblast invasion through TIMP-1 PMID: 26680220
  9. Results revealed that PEG10 high expression was closely associated with the TNM classification in lung cancer and is a critical indicator for poor prognosis. Also, It promotes significantly proliferation, migration and invasion of A549 lung cancer cells. PMID: 25199998
  10. The downregulated expression of the imprinted gene PEG10 may be an important reason for the occurrence of preeclampsia. PMID: 25526181
  11. elevated expression of PEG10 is likely to be involved in the pathophysiology of preeclampsia PMID: 22137777
  12. promotes migration of Burkitt's lymphoma cells via upregulation of matrix metalloproteinase-2 and -9 PMID: 22673314
  13. Overexpression of PEG10 and TSG101 was detected in gallbladder adenocarcinoma. PMID: 21455631
  14. PEG10 imprinting is lost in a majority of hepatocellular carcinomas and no correlation exists between the imprinting status of PEG10 and its expression in HCC tissues. PMID: 21205473
  15. the mRNA expression level of PEG10 were significantly up-regulated in tumorous liver tissues compared with corresponding nontumorous counterparts. PMID: 21767414
  16. In third trimester PEG10 was downregulated in fetal samples group PMID: 20484977
  17. PEG10 gene is imprinted, with preferential expression from the paternal allele. PMID: 11318613
  18. miR-122 may be involved in regulation of PEG10 expression hepatoma cell lines. PMID: 20460050
  19. study provides new data on the genomic organization as well as expression and translation of PEG10, a prerequisite in order to study and understand the role of PEG10 in cancer, embryonic development and normal cell homeostasis PMID: 20084274
  20. Evidence for translation initiation from an in-frame, upstream non-AUG (CUG) codon, and from the downstream AUG, resulting in different isoforms. PMID: 20084274
  21. PEG10 is a probable target, acting as a driving force for amplification of the 7q21 region, and may therefore be involved in the development or progression of hepatocellular carcinomas. PMID: 20362226
  22. placental PEG10 is downregulated at early hypoxic phase, and highly activated at 11-12 wk of gestation PMID: 12620933
  23. Exogenous expression of PEG10 conferred oncogenic activity. PEG10 protein associated with SIAH1, a mediator of apoptosis, and overexpression of PEG10 decreased the cell death mediated by SIAH1. PMID: 12810624
  24. Results indicate that the induction of the imprinted gene paternally expressed 10 (PEG10) may play an important role during liver regeneration or carcinogenesis of the human hepatocyte. PMID: 14576465
  25. Data show that CXCL13 and CCL19 together by means of activation of CXCR5 and CCR7 up-regulated PEG10 expression and function in leukemic B cells. PMID: 16225771
  26. PEG10 is a direct target of c-MYC; findings link cancer genetics and epigenetics by showing that a classic proto-oncogene, MYC, acts directly upstream of a proliferation-positive imprinted gene, PEG10 PMID: 16423995
  27. PEG10 represents a novel marker in B-cell chronic lymphocytic leukemia PMID: 17621626
  28. the ORF1-2 protein of PEG10, synthesized utilizing the most efficient -1 frameshift mechanism yet documented in vivo, will have an essential function that is intrinsic to the importance of PEG10 in mammals PMID: 17942406
  29. The results showed that maintaining sufficient levels of PEG10 may be important during early pregnancy. Lower levels of PEG10 might be one of reasons that underlie inevitable abortion. PMID: 18550496
  30. The expression profile of hepatocelluar carcinoma tissues suggested E2Fs were involved in PEG10 regulation. PMID: 18625225
  31. PEG10 contains two overlapping reading frames from which two proteins are translated by a -1 ribosomal frameshift mechanism. PMID: 15611116
  32. Programmed -1 ribosomal frameshifting in mouse and human Peg10 genes. PMID: 15767280

Show More

Hide All

Subcellular Location
Nucleus. Cytoplasm. Note=Detected predominantly in the cytoplasm of breast and prostate carcinomas, in hepatocellular carcinoma (HCC) and B-cell chronic lymphocytic leukemia (B-CLL) cells and in the Hep-G2 cell line. Colocalized with ACVRL1.
Tissue Specificity
Expressed in the cytotrophoblast layer but not in the overlying syncytiotrophoblast of the placenta. Expressed in prostate and breast carcinomas but not in normal breast and prostate epithelial cells. Expressed in the Hep-G2 cell line (at protein level).
Database Links

HGNC: 14005

OMIM: 609810

KEGG: hsa:23089

STRING: 9606.ENSP00000417587

UniGene: Hs.147492

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*